Zealand Pharma A/S at its Annual General Meeting held on March 26, 2026 announced that Iris Löw-Friedrich was elected to the Board of Directors. Jeffrey Berkowitz and Bernadette Mary Connaughton did not stand for re-election. Following the Annual General Meeting, the Board of Directors constituted itself with Martin Nicklasson and Kirsten Aarup Drejer continuing as the Chair and the Vice-Chair, respectively.
The Audit Committee will comprise Martin Nicklasson and Leonard Kruimer, with Leonard Kruimer chairing the Committee. The Remuneration Committee will comprise Enrique Conterno Martinelli and Iris Löw-Friedrich, with Martin Nicklasson chairing the Committee. The Nomination Committee will comprise Leonard Kruimer and Martin Nicklasson, with Kirsten Aarup Drejer chairing the Committee.
The Scientific Committee will comprise Elaine Sullivan, Enrique Conterno Martinelli and Iris Löw-Friedrich, with Kirsten Aarup Drejer chairing the Committee.
